Table 4. Distribution different ASM classes across WHO regions, continents, income and urbanisation status.
| ASM Classification | First generation ASM
N (%) |
Second generation ASM
N (%) |
Benzodiazepine
N (%) |
|---|---|---|---|
| Overall (N=68) | 56 (82.3) | 12 (17.6) | 1 (1.4) |
| WHO Region | |||
| African (N=19) | 18 (94.7) | - | I (5.2) |
| Americas (N=1) | 1 (100.0) | - | - |
| Eastern Mediterranean (N=2) | 2 (100.0) | - | - |
| European (N=35) | 28 (80.0) | 5 (14.2) | 2 (5.7) |
| Western Pacific (N=9) | 4 (44.4) | 5 (55.5) | - |
| P value | 0.037 | 0.005 | 1.000 |
| Continent | |||
| Africa (N=21) | 20 (95.0) | - | 1 (5.0) |
| Asia (N=9)_ | 4 (44.4) | 4 (44.4) | 1 (11.2) |
| Europe (N=35) | 28 (80.0) | 5 (14.2) | 2 (5.7) |
| South America (N=1) | 1 (100.0) | - | - |
| P value | 0.016 | 0.010 | 0.636 |
| Income status | |||
| Low-income (N=3) | 3 (100.0) | - | - |
| Lower-middle-income (N=8) | 8 (100.0) | - | - |
| Upper-middle-income (N= 62) | 49 (79.0) | 12 (19.3) | 1 (1.6) |
| P value | 0.389 | 0.475 | 1.000 |
| Urbanisation | |||
| Rural (N=7) | 7 (100.0) | - | - |
| Urban (N=65) | 52 (80.0) | 12 (18.4) | 1 (1.5) |
| P value | 0.232 | 0.262 | 0.903 |